IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.533
EU - Europa 2.795
AS - Asia 2.766
SA - Sud America 585
AF - Africa 49
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.453
SG - Singapore 1.255
IT - Italia 555
BR - Brasile 486
IE - Irlanda 484
CN - Cina 461
HK - Hong Kong 434
RU - Federazione Russa 342
VN - Vietnam 281
UA - Ucraina 248
SE - Svezia 237
DE - Germania 229
FI - Finlandia 173
FR - Francia 135
KR - Corea 119
GB - Regno Unito 107
RO - Romania 51
CZ - Repubblica Ceca 38
NL - Olanda 38
IN - India 36
AR - Argentina 35
PL - Polonia 32
CA - Canada 31
MX - Messico 30
JP - Giappone 28
ID - Indonesia 25
TR - Turchia 25
AT - Austria 24
BE - Belgio 23
BD - Bangladesh 22
EC - Ecuador 19
ZA - Sudafrica 19
UZ - Uzbekistan 15
ES - Italia 13
IQ - Iraq 13
CH - Svizzera 12
LT - Lituania 11
CO - Colombia 9
GR - Grecia 9
PY - Paraguay 9
VE - Venezuela 9
HR - Croazia 8
LB - Libano 8
MA - Marocco 7
TN - Tunisia 6
CL - Cile 5
JM - Giamaica 5
SA - Arabia Saudita 5
EG - Egitto 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PH - Filippine 4
PK - Pakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
IR - Iran 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GM - Gambi 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
Totale 9.723
Salva come PNG Salva come JPEG
Città #
Singapore 821
Chandler 512
Dublin 484
Hong Kong 433
Perugia 272
Boardman 230
San Mateo 219
Ashburn 174
Santa Clara 162
Altamura 139
Jacksonville 130
Beijing 127
Dong Ket 121
Seoul 119
Moscow 115
Munich 112
Medford 111
Princeton 110
Lawrence 105
Wilmington 93
Andover 86
Los Angeles 84
Ann Arbor 81
Des Moines 60
Ho Chi Minh City 55
Turku 54
New York 50
Piscataway 48
Helsinki 42
Redmond 40
São Paulo 39
The Dalles 39
Falls Church 34
Bucharest 33
Hanoi 28
Brno 27
Tokyo 26
Frankfurt am Main 25
Saint Petersburg 25
Warsaw 23
Brooklyn 22
Dallas 21
Denver 21
Boston 20
Brussels 20
Chennai 19
Norwalk 19
Nuremberg 19
Amsterdam 18
Chicago 18
Redwood City 18
Atlanta 17
London 17
Woodbridge 17
Houston 16
Phoenix 15
Vienna 15
Columbus 14
Montreal 14
Orem 14
Rio de Janeiro 14
Hefei 13
Johannesburg 13
San Francisco 13
Poplar 12
Timisoara 12
Ankara 11
Izmir 11
Manchester 11
Stockholm 11
Guangzhou 10
Biên Hòa 9
Den Haag 9
Falkenstein 9
Quito 9
San Paolo di Civitate 9
Shenzhen 9
Tashkent 9
Belo Horizonte 8
Campinas 8
Salvador 8
Brasília 7
Haiphong 7
Olomouc 7
Rome 7
Roubaix 7
Secaucus 7
Zagreb 7
Maceió 6
Manaus 6
Mexico City 6
Milan 6
Ninh Bình 6
Porto Alegre 6
Shanghai 6
Tianjin 6
Toronto 6
Charlotte 5
Da Nang 5
Dhaka 5
Totale 6.178
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 194
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 150
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 127
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 125
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 121
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 118
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 108
Hippocampal epileptogenesis in autoimmune encephalitis 107
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 105
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 104
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 101
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 101
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 100
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 100
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 100
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 98
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 98
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 98
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 98
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 96
Plasticity and repair in the post-ischemic brain 96
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 94
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 94
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 93
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 93
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 91
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 91
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 90
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 90
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 89
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 89
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 89
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 88
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 85
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 85
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 84
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 84
Mitochondria and the link between neuroinflammation and neurodegeneration. 83
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 83
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 82
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 82
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 82
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 78
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 78
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 78
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 77
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 76
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 76
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 75
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 74
Direct and indirect pathways of basal ganglia: a critical reappraisal. 74
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 74
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 74
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 72
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 72
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 71
The endocannabinoid system in Parkinson's disease. 70
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 70
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 70
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 70
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 69
Ischemic stroke injury is mediated by aberrant Cdk5 69
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 69
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 67
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 66
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: A multicentre retrospective study 65
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 65
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 65
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 65
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 65
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 64
Teaching NeuroImages: Acute tetraparesis: Mind the brain 64
Multiple sclerosis and cognition: synaptic failure and network dysfunction 64
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 64
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 64
Sensitization, glutamate, and the link between migraine and fibromyalgia. 63
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 63
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 63
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 62
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 62
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 61
Neurofilament light chain as a biomarker in neurological disorders 61
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 61
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 60
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 60
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 60
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 60
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 59
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 59
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 59
Serum neurofilament light chain as a preclinical marker of neurodegeneration 58
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 58
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 58
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 58
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. 57
Infliximab monotherapy for neuro-Behçet's disease: a case report 57
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 57
Neuroscience: Brain's traffic lights. 56
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 56
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases. 54
Totale 7.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 50 45 30 63 25 50 133
2021/20221.041 13 158 34 46 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/20252.227 27 203 82 106 230 175 112 209 390 136 364 193
2025/20262.627 361 368 288 772 705 133 0 0 0 0 0 0
Totale 10.064